SNN: Smith & Nephew plc - Summary | Jitta

Smith & Nephew plc

NYSE:SNN

End of day
Aug 13, 2018
Price
$35.30
Loss Chance
43.7%
7.20
Updated 2018Q2
5 months ago
Jul 28, 2018
JITTA SCORE
34.37%Above Jitta Line
Jitta Ranking
97 / 795
United States
?
NASDAQ, NYSE
1,603 / 4,758
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (25)
Recent Business Performance (30)
Financial Strength (93)
Return to Shareholders (83)
Competitive Advantage (71)
Jitta Signs
Revenue and Earning
201220132014201520162017
Revenue9.169.7510.3310.3610.6810.91
Normalized Earning609.42617.70636.42503.88630.45728.61
EPS1.351.381.421.131.441.67
Consistent
Debt Level
20132014201520162017
Net Profit (mill.)617.70636.42503.88630.45728.61
Long Term Debt (mill.)347.001,666.001,434.001,564.001,423.00
Low Long Term Debt
Dividend Payout
20132014201520162017
Dividend Per Share0.550.590.620.620.70
Dividend to Net Profit0.430.390.660.720.35
Increasing Every Year
Recent Business Performance
Earning per ShareQ1Q2Q3Q4
20180.310.31--
20170.370.370.460.46
20160.300.300.410.41
Earning decline 15.14% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
7.20
34.37%
2.44
0.48%
Healthcare Equipment
COMPANY DESCRIPTION
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery, various products, and technologies to assist in surgical treatment of the ear, nose, and throat; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.